|
|
|
|
| LEADER |
01372nam a2200253 a 4500 |
| 001 |
1818639 |
| 005 |
20171111234603.0 |
| 008 |
120711s2012 dcu sb 001 0 eng d |
| 020 |
|
|
|z 9780309225496
|
| 040 |
|
|
|a CaPaEBR
|z 0309225493
|
| 050 |
1 |
4 |
|a RJ560
|b .C666 2012eb
|
| 110 |
2 |
|
|a Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
|
| 245 |
1 |
0 |
|a Safe and effective medicines for children
|b pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
|c Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 2012.
|
| 300 |
|
|
|a xxiii, 408 p.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Pediatric pharmacology.
|
| 650 |
|
0 |
|a Drugs
|x Safety measures.
|
| 700 |
1 |
|
|a Field, Marilyn J.
|
| 700 |
1 |
|
|a Boat, Thomas F.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Board on Health Sciences Policy.
|
| 710 |
2 |
|
|a National Academies Press (U.S.)
|
| 856 |
4 |
0 |
|a ebrary, Inc.
|u http://site.ebrary.com/lib/ucy/Doc?id=10606357
|
| 952 |
|
|
|a CY-NiOUC
|b 5a045bff6c5ad14ac1ed7e87
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
